Tirzepatide is sold as Mounjaro for T2D and Zepbound for obesity in the US, and the two brands grew 110% and 123% to $7.41 billion and $4.26 billion, respectively, in the last quarter of 2025, year-on-year
Semaglutide GLP-1 has demonstrated significant efficacy for weight loss in non-diabetic individuals through various clinical trials and studies
Abdominal pain, nausea, vomiting, and diarrhea are among the gastrointestinal adverse effects linked to GLP-1 RAs
Thats why we provide ongoing support from a compassionate team of specialists
Blood Sugar Modulation GLP1-S stimulates insulin secretion in a glucose-dependent manner while suppressing glucagon release, contributing to improved postprandial glucose control[4]
Increasing the dose yourself can be harmful to your health and increase the chances of experiencing side effects with retatrutide